FDA approves Ozempic to reduce risks from chronic kidney disease in diabetes patients
Ozempic, the blockbuster GLP-1 drug that was originally approved to treat type 2 diabetes, has now also been approved by the ...
Verywell Health on MSN4d
Doctors Can Now Prescribe Ozempic to Reduce Kidney Disease Risks in Diabetes Patients
The FDA has approved popular antiobesity drug Ozempic to help protect patients with type 2 diabetes from kidney disease.
McKnight's Long-Term Care News5d
FDA expands Ozempic to treat kidney disease in people with diabetes
The US Food and Drug Administration on Tuesday approved Ozempic for adults with type 2 diabetes and chronic kidney disease (CKD). The drug is now indicated specifically to treat kidney failure, ...
People5d
FDA Approves Ozempic to Treat Kidney Disease
Ozempic becomes the first GLP-1 treatment option for people with type 2 diabetes and chronic kidney disease Mario Tama/Getty The Food and Drug Administration has approved Ozempic to reduce the ...
kcra.com6d
FDA approves Ozempic to reduce risks from chronic kidney disease in diabetes patients
BUT HE SA Ozempic, the blockbuster GLP-1 ... type 2 diabetes, has now also been approved by the U.S. Food and Drug Administration to reduce certain risks associated with chronic kidney disease ...
US FDA approves Novo Nordisk's Ozempic to cut risk of diabetic kidney disease progression
The U.S. FDA has approved Novo Nordisk's Ozempic for reducing the risk of kidney failure and disease progression, as well as ...
India TV5d
US FDA approves Novo Nordisk's Ozempic to reduce risk of kidney diseases in diabetic patients
With the FDA's approval, the medicine, chemically known as semaglutide, will become the first GLP-1 treatment option for persons with type 2 diabetes and chronic kidney disease. “Such an ...